相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D
Todd T Brown et al.
ANTIVIRAL THERAPY (2010)
Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study
Hans-Juergen Stellbrink et al.
CLINICAL INFECTIOUS DISEASES (2010)
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Roberto Pacifici
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients
Claudine Duvivier et al.
AIDS (2009)
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults
Fideline Collin et al.
AIDS (2009)
Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
Todd T. Brown et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells
Maria Ellfolk et al.
MOLECULAR PHARMACOLOGY (2009)
Abacavir-Lamivudine versus Tenofovir-Emtricitabine for Initial HIV-1 Therapy
Paul E. Sax et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Reduced bone mineral density in HIV-infected patients:: prevalence and associated factors
Charles Cazanave et al.
AIDS (2008)
Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma
Matteo Landriscina et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Bone mineral density changes during the menopause transition in a multiethnic cohort of women
Joel S. Finkelstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system
Virginia A. Triant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation
Davide Gibellini et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1-infected patients
Isabel Cassetti et al.
HIV CLINICAL TRIALS (2007)
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
Todd T. Brown et al.
AIDS (2006)
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity:: demonstrable differences in vitro and clinically
Mustafa A. Noor et al.
AIDS (2006)
Longitudinal analysis of bone density in human immunodeficiency virus-infected women
Sara E. Dolan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients
JG Jemsek et al.
CLINICAL INFECTIOUS DISEASES (2006)
HIV-1 Vpr enhances production of receptor of activated NF-kappa B ligand (RANKL) via potentiation of glucocorticoid receptor activity
JM Fakruddin et al.
ARCHIVES OF VIROLOGY (2005)
BMD is reduced in HIV-infected men irrespective of treatment
C Amiel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D
M Cozzolino et al.
AIDS (2003)
Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals
K Mondy et al.
CLINICAL INFECTIOUS DISEASES (2003)
Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans
S Mouly et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Changes in bone mineral density with age in men and women: A longitudinal study
L Warming et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir
D Nolan et al.
AIDS (2001)
分享论文
